AMSTERDAM, Sept. 26, 2016 /PRNewswire/ -- Royal Philips
(NYSE: PHG AEX: PHIA) today announced its latest integrated imaging
and treatment planning solutions for radiation oncology that will
be featured at the American Society for Therapeutic Radiology and
Oncology's (ASTRO) 58th Annual Meeting in Boston. Designed to fit the unique needs of
radiation oncology clinicians and patients, these solutions have
been developed to put more control in the hands of the clinician,
with the intent to improve workflow and operational efficiencies,
drive procedure accuracy and ultimately improve care.
Over the past few years, cancer care has evolved to deliver more
advanced treatments and technologies that do not always integrate
seamlessly. For example, the treatment plan plays a big role in
determining the quality of the treatment itself. For most patients,
this means waiting for a week or more after their simulation scan
to start their treatment, which can lead to increased anxiety.
According to the National Cancer Institute, in many cases, this not
only affects a patient's ability to cope with treatment, but also
impacts their quality of life. As technology and treatments for
cancer advance, the patient experience remains first and
foremost.
"As radiotherapy continues to evolve, our focus needs to remain
on quality and timeliness, which can be eroded by the standard work
process," said Rob Cascella, CEO,
Diagnosis and Treatment, Philips. "To address these issues,
Philips' radiation oncology solutions use intelligent automation to
simplify workflow and enhance consistency from imaging through
treatment planning so clinicians can be confident in consistently
delivering the best possible care with a patient-centric
approach."
The Philips booth (#7039) at ASTRO 2016 will showcase the
company's advanced solutions enhancing its integrated radiation
oncology approach with a full suite to help clinicians deliver
quality cancer care to improve both the patient and staff
experience including the following:
- CT Big Bore v4.2 with Tumor LOC and
iPatient Platform – A trusted CT simulation solution
designed for every cancer patient, delivering accuracy, reliability
and an efficient workflow to drive clinical confidence in cancer
treatment. Now integrated with both Philips' Tumor LOC technology
and iPatient Platform, Big Bore offers more powerful simulation and
advanced marking tools to help speed time to treatment.
- Powered by Pinnacle3, TumorLOC integrates scanning
and planning to simplify and accelerate patient marking and CT
simulation at the scanner console.
- Philips' iPatient platform provides consistent image quality
from scan-to-scan through patient-centered workflows for both
routine and advanced 4D imaging applications, making patient setup
fast and easy.
- Ingenia MR-RT - a dedicated MR simulation platform providing
clinicians with high quality MR images acquired in the treatment
position to help visualize targets and critical structures,
allowing them to design the best possible treatment plans. The
recently 510(k) cleared MR-only simulation for prostate treatment
planning is a continuation of Philips's commitment of making MR
more accessible to radiation oncology by simplifying workflows.
Philips aims to further streamline the often repetitive and
time-consuming process from imaging to treatment planning with
intelligent workflow automation with the goal to further speed time
to treatment and to enhance consistency. At ASTRO, Philips
will showcase developments in intelligent workflow automation, such
as automated contouring on MR-only based datasets1.
1Work in Progress
- Pinnacle3 - A leader in radiation
treatment planning with fast, accurate and interactive treatment
planning tools. Now with a new intuitive user interface, Pinnacle³
offers seamless integration that enhances planning efficiency and
quality while making plan workflow faster and less iterative.
Pinnacle3 intelligent automation simplifies and
accelerates the IMRT and VMAT planning process. Smart automation
tools enable the user to create plans with limited clinician
intervention while reducing the dose variability of manual planning
workflows.
For more information about Philips' presence at ASTRO, including
the full suite of Philips radiation oncology technology and
integrated solutions, please visit Philips' ASTRO event website,
and follow @PhilipsLiveFrom for more information on Philips'
presence at #ASTRO16.
For further information, please contact:
Adrienne Smith
Philips Diagnosis and Treatment
Tel: + 1 781-277-1170
Adrienne.Smith@Philips.com
Kathy O'Reilly
Philips Group Communications
Tel: +1 978-221-8919
Email: Kathy.Oreilly@Philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better
outcomes across the health continuum from healthy living and
prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. The
company is a leader in diagnostic imaging, image-guided
therapy, patient monitoring and health informatics, as
well as in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-unveils-patient-centric-advanced-radiation-oncology-imaging-and-treatment-planning-innovations-at-astro-2016-300333731.html
SOURCE Royal Philips